EUVIMEDEUVIMED entdecken
Crossref

Cytotoxic effects of cannabidiol on human metastatic melanoma cells: a potential therapeutic strategy?

Moreira, Maria, Natanael Videira, Rocha, Verónica, José A. M. Catita, Sérgio V. P. Barreira, Araújo, Ana Margarida, Carvalho, Márcia

Science Letters · 07.05.2025

DOI: 10.48797/sl.2025.380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 07.05.2025. Verfasst von Moreira und 10 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma is the most aggressive form of skin cancer, responsible for the majority of skin cancer-related deaths due to its high metastatic potential and resistance to treatment [1]. The limited efficacy of systemic therapies in treating this disease underscores the need to explore novel therapeutic strategies. Cannabidiol (CBD), a bioactive compound from Cannabis sativa, has shown anticancer properties in various cancer models [2,3]. However, its effects on melanoma cells and its potential selectivity remain under investigation.

Objective

This study evaluates the cytotoxic effects of CBD on human metastatic melanoma cells.

Methods

Two melanoma cell lines (A375 and MeWo) and a normal human keratinocyte cell line (HaCaT) were treated with CBD (0.05-100 µM) for 24 and 48 hours. Cell viability was assessed by the MTT assay, and morphological changes were analyzed by inverted light microscopy.

Results

CBD reduced cell viability in a concentration-dependent manner in all cell lines. HaCaT cells were the most sensitive with IC50 values at 24 h of 4.1 µM, followed by A375 (IC50 5.1 µM) and MeWo (IC50 5.8 µM) cells. Similar values were observed at 48 h (p > 0.05), indicating no significant time-dependent effect. Morphological changes were observed in all cell lines, becoming more pronounced with increasing CBD concentration and exposure time.

Conclusions

CBD is a promising candidate for melanoma management. However, its non-selective cytotoxicity toward melanoma cells remains a major challenge for safe clinical application. Ongoing research aims to elucidate the molecular mechanisms underlying CBD-induced cytotoxicity and to explore strategies for improving selectivity, potentially enhancing its clinical applicability in melanoma treatment.

Schlagwörter

cannabidiolmetastatic melanomacytotoxicityCannabis sativaA375 cellsMeWo cellsHaCaT keratinocytescell viabilityanticancer agents

Zitieren

APA

Moreira, Maria, Videira, N., Rocha, Verónica, Catita, J. A. M., Barreira, S. V. P., Araújo, Margarida, A., Carvalho, & Márcia (2025). Cytotoxic effects of cannabidiol on human metastatic melanoma cells: a potential therapeutic strategy?. Science Letters. https://doi.org/10.48797/sl.2025.380

Vancouver

Moreira, Maria, Videira N, Rocha, Verónica, Catita JAM, et al. Cytotoxic effects of cannabidiol on human metastatic melanoma cells: a potential therapeutic strategy?. Science Letters. 2025. doi:10.48797/sl.2025.380

BibTeX
@article{Moreira2025,
  author = {Moreira and Maria and Videira, Natanael and Rocha and Verónica and Catita, José A. M. and Barreira, Sérgio V. P. and Araújo and Margarida, Ana and Carvalho and Márcia},
  title = {Cytotoxic effects of cannabidiol on human metastatic melanoma cells: a potential therapeutic strategy?},
  journal = {Science Letters},
  year = {2025},
  doi = {10.48797/sl.2025.380}
}
Kostenlos starten →